Comparison of vaginal and sublingual misoprostol for second trimester abortion: Randomized controlled equivalence trial

Human Reproduction

Volumn 24, Issue 1, 2009, Pages 106-112

  Von Hertzen, Helena ^a   Piaggio, Gilda ^a   Wojdyla, Daniel ^b   Huong, Nguyen Thi My ^a   Marions, Lena ^c   Okoev, Georgy ^d   Khomassuridze, Archil ^e   Kereszturi, Attila ^f   Mittal, Suneeta ^g   Nair, Rajasekharan ^h   Daver, Rekha ⁱ   Pretnar Darovec, Alenka ^j   Dickson, Kim ^k   Hinh, Nguyen Duc ^l   Bao, Nguyen Huy ^m   Tuyet, Hoang Thi Diem ⁿ   Peregoudov, Alexandre ^a  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

^b Centro Rosarino de Estudios Perinatales   (Argentina)

^c KAROLINSKA INSTITUTE   (Sweden)

^d Research Center of Maternal and Child Health Protection   (Armenia)

^e Zhordania Inst of Hum Reproduction   (Georgia)

^f UNIVERSITY OF SZEGED   (Hungary)

^g ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^h Department of Obstetrics   (India)

ⁱ SIR J J GROUP OF HOSPITALS   (India)

^j Univ Dept of Obstet and Gynaecol   (Slovenia)

^k Reproductive Health and HIV Research Unit   (South Africa)

^l Inst Protect Mother and Newborn   (Viet Nam)

^m Department of Research and Training   (Viet Nam)

ⁿ Tu du Hospital   (Viet Nam)

more..

Author keywords

Induced abortion; Misoprostol; Second trimester; Sublingual; Vaginal

Indexed keywords

ANALGESIC AGENT; MISOPROSTOL; PLACEBO;

ADULT; ARTICLE; CHILL; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DIZZINESS; DRUG EFFICACY; DRUG FEVER; FEMALE; FEVER; GESTATIONAL AGE; HEADACHE; HUMAN; INCOMPLETE ABORTION; MAJOR CLINICAL STUDY; MEDICAL ABORTION; NAUSEA; NULLIPARA; PERCEPTION; PREGNANCY TERMINATION; PREGNANT WOMAN; PROBABILITY; RANDOMIZED CONTROLLED TRIAL; SECOND TRIMESTER ABORTION; SECOND TRIMESTER PREGNANCY; TREATMENT OUTCOME; VOMITING;

EID: 57749184724     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/den328     Document Type: Article

References (15)

1. Aronsson A, Bygdeman M, Gemzell-Danielsson K. Effects of misoprostol on uterine contractility following different routes of administration. Hum Reprod 2004;19:81-84.
2. Ashok PW, Templeton A, Wagaarachchi PT, Flett GMM. Midtrimester medical termination of pregnancy: a review of 1002 consecutive cases. Contraception 2004;69:51-58.
3. Dickinson JE, Evans SF. The optimization of intravaginal misoprostol dosing schedules in second trimester pregnancy termination. Am J Obstet Gynecol 2002;186:470-474.
4. Fiala C, Gemzell-Danielsson K, Tang OS, von Hertzen H. Cervical priming with misoprostol prior to transcervical procedures. Int J Gynaecol Obstet 2007;99(Suppl 2):S168-S171.
5. Hamoda H, Ashok PW, Flett GM, Templeton A. A randomized controlled trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion up to 13 weeks of gestation. BJOG 2005;112:1102-1108.
6. Krzymowski T, Stefańczyk-Krzymowska S, Koziorowski M. Counter current transfer of PGF2 alpha in the mesometrial vessels as a mechanism for prevention of luteal regression in early pregnancy. Acta Physiol Pol 1989;40:23-34.
7. Piaggio G, Elbourne DR, Altman DG, Pocock SJ, Evans SJ. CONSORT Group- Reporting of noninferiority and equivalence randomized trials: an extension of the CONSORT statement. JAMA 2006; 295:1152-1160.
8. Royal College of Obstetricians and Gynaecologists. The Care of Women Requesting Induced Abortion. London: Royal College of Obstetricians and Gynaecologists, 2004.
9. Tang OS, Chan CCW, Ng EHY, Lee SWH, Ho PC. A prospective, randomised, placebo-controlled trial on the use of mifepristone with sublingual or vaginal misoprostol for medical abortions of less than 9 weeks gestation. Hum Reprod 2003;18:2315-2318.
10. Tang OS, Lau WNT, Chan CCW, Ho PC. A prospective randomised comparison of sublingual and vaginal misoprostol in second trimester termination of pregnancy. BJOG 2004;111:1001-1005.
11. Tang OS, Gemzell-Danielsson K, Ho PC. Misoprostol: Pharmacokinetic profiles, effects on the uterus and side-effects. Int J Gynaecol Obstet 2007;99(Suppl 2):S160-S167.
12. von Hertzen H, Piaggio G, Huong NTM, Arustamyan K, Cabezas E, Gomez M, Khomassuridze A, Shah R, Mittal S, Nair R et al. Efficacy of two intervals and two routes of administration of misoprostol for termination of early pregnancy: a randomized controlled equivalence trial. Lancet 2007;369: 1938-1946.
13. Wong KS, Ngai CSW, Yeo ELK, Tang LCH, Ho PC. A comparison of two regimens of intravaginal misoprostol for termination of second trimester pregnancy: a randomized comparative trial. Hum Reprod 2000; 15:709-712.
14. World Health Organization. Medical Methods for termination of pregnancy. Report of a WHO Scientific Group. Geneva: World Health Organization, 1997.
15. World Health Organization. Safe Abortion: Technical and Policy Guidance for Health Systems. Geneva: World Health Organization, 2003.